Drug Value & Market Access Optimization (2016)

The “Drug Value & Market Access Optimization” report has been designed as a working tool to help pharmaceutical companies optimize the valuation of their drugs. This report reviews:

  • The economic and healthcare environment
  • The R&D cost of drugs
  • The drug pricing strategic approaches of pharmaceutical companies, governments and payers
  • The market access processes in selected countries (France, Germany, Italy, Spain, UK and USA)
  • The best practices in market access
  • The ways to leverage the corporate reputation of pharma companies




  • Electronic copy: 200 pages (PowerPoint)
  • Language: English
Consult the abstract
€ 5,000
excl (. taxes), including a 2-hour workshop in Paris area or by TC; and an unlimited use within the legal entity purchasing the report